POISE DATAENGINE

K040969 · Poise Technology Corporation · MWI · Jun 8, 2004 · Cardiovascular

Device Facts

Record IDK040969
Device NamePOISE DATAENGINE
ApplicantPoise Technology Corporation
Product CodeMWI · Cardiovascular
Decision DateJun 8, 2004
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 870.2300
Device ClassClass 2
AttributesSoftware as a Medical Device

Intended Use

DataEngine is indicated for use in data collection and clinical information management either directly or through networks with independent bedside devices. DataEngine is not intended for monitoring purposes, nor is the software intended to control any of the clinical devices ( independent bedside devices / information systems ) it is connected to.

Device Story

POISE DataEngine is a software solution for integrating medical device data into Hospital Information Systems (HIS). It collects data from independent bedside devices in real-time, either directly or via networks; transforms data into XML and HL7 formats; and stores information in a database server. Used by nurses and caregivers to automate data entry, replacing manual scripting. Output is used for patient records, research, education, and clinical studies. Does not monitor patients or control connected devices.

Clinical Evidence

Bench testing only. No clinical data provided.

Technological Characteristics

Server-based software application. Connectivity via network to bedside devices. Data output formats include XML, HL7, and database formats. Supports waveform information. Not patient-contacting; does not control life-sustaining devices.

Indications for Use

Indicated for data collection and clinical information management from independent bedside devices. Not for patient monitoring or control of clinical devices.

Regulatory Classification

Identification

A cardiac monitor (including cardiotachometer and rate alarm) is a device used to measure the heart rate from an analog signal produced by an electrocardiograph, vectorcardiograph, or blood pressure monitor. This device may sound an alarm when the heart rate falls outside preset upper and lower limits.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ 2.1 K040969 page 1 of 2 ## 2. ADMINISTRATIVE INFORMATION ## 510(k) Summary - 1. Identification of the Device: - Proprietary name: POISE DataEngine . - Common Name : Patient Physiological Monitor . - Classification number: MWI, Class II . - Regulation Number: 870.2300 . ## 2. Equivalent legal marketed device: - CAPSULE TECHNOLOGIE . - Datacaptor, K032142 . - 3. Indications for Use ( intended use ) : - DataEngine is indicated for use in data collection and clinical ● information management either directly or through networks with independent bedside devices. DataEngine is not intended for monitoring purposes, nor is the software intended to control any of the clinical devices ( independent bedside devices / information systems ) it is connected to. - 4. Description of the Device: - DataEngine is a comprehensive solution to integrate medical ● device data into HIS. It is also designed to be compatible with XML and HL7. All data collected from medical device is able to transfer to readable format of XML and HL7. Caregiver or nurses will be beneficial from DataEngine, device connectivity software to collect data in real time and receive a complete electronic data for patient's record. Medical staffs do not have to spend much time on manual script. Every patient's real time data will be stored in database server for future research projects, education, and clinical study. 5. Safety and Effectiveness, comparison to predicate devices: Similarities - Same intended use ● - Same output mode ● - Same technological characteristics software server application, ● not contact with the patients, not controlling any life sustaining devices {1}------------------------------------------------ <840969 page 2 of 2 Differences - Performance differences ● - Can output format other than just text file . - Support wave form information for some device 그 - Support HL7 & Database ■ - Can output in Database format, easier to organize 1999 - Easy to learn 트 - 6. Conclusion: - The new device and the predicate device utilize the similar . technologies and design aspects. The subject device is very toonhologics and performs the same clinical function as the predicate olmillar arra personal distinguishing characteristics of the subject device are more convenience usage than the predicate device, and they are considered to be substantially equivalent. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo consists of a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of an eagle. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 JUN - 9 2004 Poise Technology Corporation c/o Ke-Min Jen, Ph.D. No. 58 . Fu-Chiun Street Hsin Chu City, 300 Taiwan, ROC Re: K040969 Trade Name: POISE DataEngine Regulation Number: 21 CFR 870 2300 Regulation Name: Cardiac Monitor (including cardiotachometer and rate alarm) Regulatory Class: II (two) Product Code: MWI Dated: May 23, 2004 Received: May 26, 2004 Dear Dr. Jen: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ Page 2 -- Ke-Min Jen, Ph.D. Please be advised that FDA's issuance of a substantial equivalence determination does not mean Please be advised film I DA 3 issualto of a business with other requirements of the Act that FDA has made a determination that your device complies with other requirements of that FDA has made a decommation and Journer Federal agencies. You must or any Federal statures and regulations daminities, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set CFR Part 807), labeling (21 CFR Part 820); and 820); and if applicable, the electronic forth in the quality systems (Sections 531-542 of the Act); 21 CFR 1000-1050. product radiation control provisions (Dections your device as described in your Section 510(k) I ms letter will anow you to ogin maneting of substantial equivalence of your device to a legally premarket notheation: "The PDF mining of casion for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please If you desire specific advice for your as 110 % 0.0 % 0.0 % 0.0 % 0.0 % 0.7 % % % % % Colliant the Office of Comphalled as (SS +) + + + + + 807.97). You may obtain "Misoranding by reference to promance notifies under the Act from the Division of Small other geleral information on your responsions is and its toll-free number (800) 638-2041 or Manufacturers, International and Consess http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, Qolly P. All Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ ## Ko4096 2.2 FDA Indication for Use Form : | Applicant: | POISE TECHNOLOGY CORPORATION | |-----------------|------------------------------| | 510(k) Number : | TO BE ASSIGNED | | Device Name: | POISE DataEngine | Indications for Use : - DataEngine is indicated for use in data collection and clinical ● information management either directly or through networks with independent bedside devices. DataEngine is not intended for monitoring purposes, nor is the software intended to control any of the clinical devices ( independent bedside devices / information systems ) it is connected to. Prescription Use (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Hith P. All for BDZ (Division Sign-Off) Division of Cardiovascular Devices 510(k) Number *k040969*
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...